Related Experiment Video

Updated: Aug 6, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Inpatient diabetes: review of data from the cardiac care unit

Irl B Hirsch1

  • 1Department of Medicine, Division of Metabolism, Endocrinology & Nutrition, University of Washington School of Medicine, Seattle, Washington, USA.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|August 15, 2006
PubMed

Insights

Hyperglycemia is a mortality risk in critically ill patients, especially those with myocardial infarction. Aggressive glucose control is crucial for improving outcomes in these patients.

Area of Science:

  • Critical care medicine
  • Endocrinology
  • Cardiology

Background:

  • Hyperglycemia is a common complication in critically ill patients.
  • The impact of glucose control on mortality in this population is still under investigation.
  • Myocardial infarction (MI) patients represent a key subgroup for glucose control studies.

Purpose of the Study:

  • To review existing studies on glucose control in critically ill patients.
  • To assess the effect of glucose control on mortality and other outcomes.
  • To specifically analyze data from patients with myocardial infarction.

Main Methods:

  • Review of prospective and retrospective studies.
  • Detailed analysis of study results, focusing on glucose levels and mortality.
  • Examination of data from patients with myocardial infarction (MI).

Main Results:

  • Hyperglycemia remains a significant risk factor for mortality, even with interventions like percutaneous coronary interventions.
  • Prospective studies using glucose-insulin-potassium infusions did not meet primary mortality endpoints, but progressive hyperglycemia was linked to increased death risk.
  • A potential protective effect of diabetes in MI patients was observed, possibly due to increased insulin use.

Conclusions:

  • Further research, including studies on variable-rate intravenous insulin infusion, is warranted.
  • Clinicians should prioritize achieving optimal glucose control in all acute MI patients with hyperglycemia.
  • Aggressive management of hyperglycemia is essential for improving outcomes in critically ill populations.
Abstract

Related Concept Videos

Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...